• Affymetrix (Santa Clara, California) (AFFX) Drops Purchase Price for eBioscience, Inc. to $315 Million Cash More...

• Marken Acquires European Kit Building Operation From LabCorp Clinical Trials More...

• Genomma Lab Internacional, S.A.B. de C.V. Announces Decision Not to Pursue Acquisition of Prestige Brands Holdings More...

• Wintherix and Epitherix Reaches an Agreement With Pfizer Inc. (PFE) and the Pfizer Incubator More...

• Merus Labs International Inc. Announces CAD$10,000,800 Bought Deal Common Share Financing More...

• ACM Global Central Laboratory Announces Isabel Struikas Head of Business Development, Europe More...

• Virginia Biotechnology Association Executive Director Mark Herzog to Depart June 1 for New Position More...

• Amicus Therapeutics, Inc. (FOLD) to Announce First Quarter 2012 Financial Results on May 10, 2012 More...

• Aceto Corporation Announces Fiscal 2012 Third Quarter Results of Operations More...

• Alnylam Pharmaceuticals (ALNY) Reports First Quarter 2012 Financial Results More...

• Affymetrix (Santa Clara, California) (AFFX) Reports First Quarter 2012 Results More...

• Anika Therapeutics (ANIK) Reports Record First-Quarter Revenue and Earnings More...

• Feds Arrest Thieves Who Fleeced Eli Lilly and Company (LLY) Warehouse in $70 Million Heist More...

• Pfizer Inc. (PFE)'s Lyrica Fails Two Pain Studies More...

• Raptor Pharmaceutical Inc. (RPTP) Announces Publication of Phase 3 Results in the Clinical Journal of the American Society of Nephrology More...

• Argos Therapeutics, Inc. Gets Encouraging Results from Study More...

• CSL Behring Initiates Study of Subcutaneous Administration of C1-esterase Inhibitor in Patients with Hereditary Angioedema More...

• Accentia Biopharmaceuticals (ABPI) Conducts Investigator Meeting in Preparation for New Multiple Sclerosis Drug Study for Cyrevia™ More...

• Alexza Pharmaceuticals, Inc. (ALXA) Slammed with a CRL for Adasuve™ More...

• U.S. Panel Seen Backing Pfizer Inc. (PFE)'s Arthritis Drug Hope More...

• Gentium S.p.A. Receives Day 180 List of Outstanding Issues From the CHMP for Defibrotide MAA More...

• Immunomic Therapeutics Receives IND Authorization for Phase I Study of JRC-LAMP-Vax Vaccine to Treat Japanese Red Cedar (Sugi) Allergy More...

• Napo Pharmaceuticals, Inc. Comments on FDA Announcing Extension of Crofelemer NDA Priority Review More...

• Pfizer Inc. (PFE), Eli Lilly and Company (LLY) Help U.S. Test Failed Drugs for New Illness, National Institutes of Health (NIH) Reveals More...

• Why You Overeat Even When You're Full, University of Scranton Study More...

• Joggers Live Longer, Bispebjerg University Hospital Study More...

• Research Explores the Positives of Bipolar Disorder, Lancaster UniversityStudy More...

• Brain Sees Metaphor and Simile Differently, Hokkaido University Study More...

• Microbix Biosystems Inc. (MBXBF) Release: European Patent Office Revokes Controversial Patent More...

• Integral Molecular, Inc. Announces Patent Allowance for its Membrane Protein Lipoparticle Technology More...

• Meda AB (MEDA-A.ST): Dymista - Could be the Drug of Choice More...